What results are reported with GLOW or KLOW, and over what timeframe
Includes options like gastric bypass, sleeve gastrectomy, or banding
the expected effect size is small and the onset is slow - Avoid antidepressants in bipolar depression presenting with subtle increased psychomotor tempo, pressured speech and racing thoughts due to the increased risk of switch and potentially rapid cycling - Consider ETC as a viable option for the treatment of bipolar depression resistant to pharmacological treatment - Never treat with antidepressants without a mood stabiliser - If an antidepressant is added, use mainly SSRIs due to their low switch rate - If an antidepressant is used in maintenance treatment, the occurrence of manic/mixed symptoms should be monitored carefully The above recommendation is consistent with current Danish guidelines for the pharmacological treatment of bipolar disorder [42], which recommend lithium, quetiapine and lamotrigine as first-line agents for bipolar I disorder, current depressive episode, in at least 70% of patients, and for bipolar II disorder, current depressive episode, in at least 60%
(But hope springs eternal.) I enjoyed this relevant article about Professor Mike Snyder's quantified self project that just appeared in Stanford Magazine in Dec, 2021
Skin changes in the obese patient
The most serious complications described did not stem from glutathione itself, but from contaminated raw material used to prepare the infusion (PMID 29673413)
